Liriodenine enhances radiosensitivity in esophageal cancer ECA‑109 cells by inducing apoptosis and G2/M arrest

  • Authors:
    • Gang Wu
    • Guangzong Chen
    • Jialiang Zhou
    • Hongcheng Zhu
    • Jianjun Chu
    • Fuzheng Zhang
  • View Affiliations

  • Published online on: August 2, 2018     https://doi.org/10.3892/ol.2018.9253
  • Pages: 5020-5026
  • Copyright: © Wu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

At present, chemotherapy and radiotherapy represent the primary modalities of treatment for patients with unresectable esophageal squamous cell carcinoma (ESCC). However, the outcome of patients remains poor owing to radioresistance. The present study aimed to determine the radiosensitizing effect of liriodenine, an aporphine alkaloid derived from Enicosanthellum pulchrum, and investigating the underlying mechanisms in ESCC, using the esophageal cancer ECA‑109 cell line. Cellular proliferation was evaluated using the Cell Counting kit‑8 assay. Colony formation assay was performed to characterize the radiosensitive effects of liriodenine on ECA‑109 cells, and flow cytometry was used to detect the percentage of cells undergoing apoptosis. An immunofluorescence assay was utilized to evaluate the DNA damage repair ability. Western blotting was used to assess the protein levels of caspase‑3, B cell lymphoma‑2 (Bcl‑2) and Bcl‑2‑associated X (Bax). Liriodenine dose‑dependently inhibited ECA‑109 cell viability. The clonogenic survival assay demonstrated that liriodenine increased the radiosensitivity of ESCC cells, with a sensitization enhancement ratio of 1.11‑1.69. The results of flow cytometry demonstrated that liriodenine induced apoptosis and G2/M arrest. The immunofluorescence assay revealed that liriodenine delays DNA damage repair. The upregulation of Bax and Caspase‑3, and the suppression of Bcl‑2 confirmed that apoptosis was occurring. Liriodenine radiosensitizes ECA‑109 cells by inducing apoptosis and G2/M arrest. The findings of the present study indicated that liriodenine may represent an anticancer agent with promising potential for the treatment of ESCC.
View Figures
View References

Related Articles

Journal Cover

October-2018
Volume 16 Issue 4

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wu G, Chen G, Zhou J, Zhu H, Chu J and Zhang F: Liriodenine enhances radiosensitivity in esophageal cancer ECA‑109 cells by inducing apoptosis and G2/M arrest. Oncol Lett 16: 5020-5026, 2018.
APA
Wu, G., Chen, G., Zhou, J., Zhu, H., Chu, J., & Zhang, F. (2018). Liriodenine enhances radiosensitivity in esophageal cancer ECA‑109 cells by inducing apoptosis and G2/M arrest. Oncology Letters, 16, 5020-5026. https://doi.org/10.3892/ol.2018.9253
MLA
Wu, G., Chen, G., Zhou, J., Zhu, H., Chu, J., Zhang, F."Liriodenine enhances radiosensitivity in esophageal cancer ECA‑109 cells by inducing apoptosis and G2/M arrest". Oncology Letters 16.4 (2018): 5020-5026.
Chicago
Wu, G., Chen, G., Zhou, J., Zhu, H., Chu, J., Zhang, F."Liriodenine enhances radiosensitivity in esophageal cancer ECA‑109 cells by inducing apoptosis and G2/M arrest". Oncology Letters 16, no. 4 (2018): 5020-5026. https://doi.org/10.3892/ol.2018.9253